Centrifugal Blood Pump Market is Grabbing New opportunities by International Key Players (Getinge AB, Maquet, Senko Medical Instrument Mfg. Co., Ltd., Braile Biomedica Ltd.) | Forecast to 2027

Centrifugal Blood Pump Market Scope:
Market size value in 2023 - USD 72.2 Million
Market size value in 2030 - USD 99.2 Million
CAGR (2023-2030) - 4.64%
Forecast Period - 2023-2030
Segments Covered - Application, End-user & Region.
Geographies Covered - North America, Europe, Asia Pacific, and Row
Sample of Companies Covered - Qura S.r.l, Braile Biomedica Ltd., LivaNova, PLC, Getinge AB, Maquet, Senko Medical Instrument Mfg. Co., Ltd., Braile Biomedica Ltd., Eurosets, Thoratec Corporation.

Download Sample Pages-https://www.marketdigits.com/request/sample/3394

Browse in-depth TOC on "Centrifugal Blood Pump Market"
178-Tables
95-Figures
332-Pages

North America dominates the market for Global Centrifugal Blood Pump.
In 2022, North America emerged as the dominant force in the market, claiming the largest share of revenue. Factors such as increased research and development spending, a growing prevalence of cardiovascular disorders, and concerted efforts by key market players to develop advanced centrifugal blood pumps in the U.S. and Canada contributed to North America's substantial market leadership. The region's technologically advanced healthcare infrastructure is expected to facilitate a higher number of treatments, driving an escalated demand for centrifugal pumps. The rising incidence of cardiovascular disorders in both the U.S. and Canada is projected to fuel the need for centrifugal blood pumps in applications such as ECMO, ventricular assistance, and cardiopulmonary bypass.
The Asia Pacific region is expected to experience rapid growth, driven by the expanding geriatric population. Notably, China, with the world's largest and fastest-aging population, is a key contributor to this trend. The demographic shift in China results from decades of declining birth rates juxtaposed with a considerable increase in life expectancy. The aging population in China is poised to present substantial challenges in the years to come. Given that the risk of Cardiovascular Disease (CVD) tends to rise with age, the elderly population is more susceptible to developing cardiac issues, thereby influencing the demand for centrifugal blood pumps in the country.

Ask for Discount- https://www.marketdigits.com/request/discount/3394

Top Key Players Covered in the Report-
MEDTRONIC PLC., Abbott, Terumo Corporation, Qura S.r.l, Braile Biomedica Ltd., LivaNova, PLC, XENIOS AG (Fresenius Medical Care Company), Getinge AB, Maquet, Senko Medical Instrument Mfg. Co., Ltd., Braile Biomedica Ltd., Eurosets, Thoratec Corporation and Others.

For More Information - Inquire Now!
https://www.marketdigits.com/request/enquiry-before-buying/3394

Recent Developments-
• In May 2023, Getinge announced that it had acquired Circulatory Support Technologies, a company that develops and markets centrifugal blood pumps for ECMO procedures. The acquisition is expected to expand Getinge's portfolio of cardiovascular products.
• In April 2023, LivaNova announced that it had received FDA approval for its INCOR pre-implantation conditioning system. The INCOR system is designed to improve the survival rates of organs that are being transplanted.

https://industrytoday.co.uk/market-research-industry-today/emerging-trends-and-innovations-for-the-centrifugal-blood-pump-market-projected-to-reach-usd-1804413-thousands-by-2030

MarketDigits
Email: sales@marketdigits.com

MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that a market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.

This release was published on openPR.